Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michel Fardeau

Showing results (11-20 of 79) with videos related to

Pageof 8
Sort By:
Handbook of Clinical Neurology|April 30, 2013
Myofibrillar myopathiesKristl G Claeys, Michel Fardeau
Neuromuscular Disorders : NMD|September 5, 2002
Desmin - Protein Surplus Myopathies, 96th European Neuromuscular Centre (ENMC)-sponsored International Workshop held 14-16 September 2001, Naarden, The NetherlandsHans H Goebel, Michel Fardeau
Medecine Sciences : M/S|November 22, 2016
[About the technique of muscle biopsy (III). The contribution of elctron microscopy, yesterday, and at the time of the molecular genetics era. A historical overview]Michel Fardeau, Andrée Rouche, Stéphane Vassilopoulos, et al.
Neuromuscular Disorders : NMD|July 4, 2008
156th ENMC International Workshop: desmin and protein aggregate myopathies, 9-11 November 2007, Naarden, The NetherlandsHans H Goebel, Michel Fardeau, Montse Olivé, et al.
Neuromuscular Disorders : NMD|May 29, 2002
Glucocorticoid treatment induces expression of small heat shock proteins in human satellite cell populations: consequences for a desmin-related myopathy involving the R120G alpha B-crystallin mutationPatrick Nédellec, Ylva Edling, Emmanuelle Perret, et al.
Neuromuscular Disorders : NMD|January 21, 2011
Sporadic centronuclear myopathy with muscle pseudohypertrophy, neutropenia, and necklace fibres due to a DNM2 mutationNorma Beatriz Romero, Jorge A Bevilacqua, Anders Oldfors, et al.
Neuromuscular Disorders : NMD|September 11, 2002
Current protocol of a research phase I clinical trial of full-length dystrophin plasmid DNA in Duchenne/Becker muscular dystrophies. Part I: rationaleChristine Thioudellet, Stéphane Blot, Patrick Squiban, et al.
Muscle & Nerve|February 3, 2004
EMG and nerve conduction studies in children with congenital muscular dystrophySusana Quijano-Roy, Francis Renault, Norma Romero, et al.
Bulletin De L'Academie Nationale De Medecine|August 13, 2015
[Congenital myasthenic syndromes; French experience]Bruno Eymard, Daniel Hantaï, Emmanuel Fournier, et al.
Neuromuscular Disorders : NMD|May 3, 2011
Telethonin-deficiency initially presenting as a congenital muscular dystrophyAna Ferreiro, Monica Mezmezian, Montse Olivé, et al.
Pageof 8

Showing results (11-20 of 79) with videos related to

Sort By:
Pageof 8
Handbook of Clinical Neurology|April 30, 2013
Myofibrillar myopathiesKristl G Claeys, Michel Fardeau
Neuromuscular Disorders : NMD|September 5, 2002
Desmin - Protein Surplus Myopathies, 96th European Neuromuscular Centre (ENMC)-sponsored International Workshop held 14-16 September 2001, Naarden, The NetherlandsHans H Goebel, Michel Fardeau
Medecine Sciences : M/S|November 22, 2016
[About the technique of muscle biopsy (III). The contribution of elctron microscopy, yesterday, and at the time of the molecular genetics era. A historical overview]Michel Fardeau, Andrée Rouche, Stéphane Vassilopoulos, et al.
Neuromuscular Disorders : NMD|July 4, 2008
156th ENMC International Workshop: desmin and protein aggregate myopathies, 9-11 November 2007, Naarden, The NetherlandsHans H Goebel, Michel Fardeau, Montse Olivé, et al.
Neuromuscular Disorders : NMD|May 29, 2002
Glucocorticoid treatment induces expression of small heat shock proteins in human satellite cell populations: consequences for a desmin-related myopathy involving the R120G alpha B-crystallin mutationPatrick Nédellec, Ylva Edling, Emmanuelle Perret, et al.
Neuromuscular Disorders : NMD|January 21, 2011
Sporadic centronuclear myopathy with muscle pseudohypertrophy, neutropenia, and necklace fibres due to a DNM2 mutationNorma Beatriz Romero, Jorge A Bevilacqua, Anders Oldfors, et al.
Neuromuscular Disorders : NMD|September 11, 2002
Current protocol of a research phase I clinical trial of full-length dystrophin plasmid DNA in Duchenne/Becker muscular dystrophies. Part I: rationaleChristine Thioudellet, Stéphane Blot, Patrick Squiban, et al.
Muscle & Nerve|February 3, 2004
EMG and nerve conduction studies in children with congenital muscular dystrophySusana Quijano-Roy, Francis Renault, Norma Romero, et al.
Bulletin De L'Academie Nationale De Medecine|August 13, 2015
[Congenital myasthenic syndromes; French experience]Bruno Eymard, Daniel Hantaï, Emmanuel Fournier, et al.
Neuromuscular Disorders : NMD|May 3, 2011
Telethonin-deficiency initially presenting as a congenital muscular dystrophyAna Ferreiro, Monica Mezmezian, Montse Olivé, et al.
Pageof 8